February 2, 2026- The Health Industry Distributors Association (HIDA) announced that Kelley Moffett, Senior Vice President of Quality, Regulatory and Medical Affairs for Cardinal Health’s Global Medical Products and Distribution (GMPD) business, will serve as Chair of the HIDA Board of Directors in 2026. Moffett succeeds 2025 Chair Lisa Hohman, CEO of Concordance Healthcare Solutions.
“We are thrilled to work with a leader of Kelley’s caliber as HIDA’s 2026 Chairman of the Board,” said HIDA President and CEO Matthew J. Rowan. “Her deep industry knowledge, accumulated through a range of executive roles in healthcare, will inform her leadership of HIDA as the industry navigates an increasingly complex environment.”
“Advancing the essential role of distribution in a high-performing healthcare industry has never been more important, or more challenging,” said Moffett. “I am honored to serve as HIDA Chair and to work alongside our members to strengthen collaboration, preparedness and trust across the healthcare supply chain.”
For her tenure as Board Chair, Moffett has outlined four key priorities for HIDA in the year ahead: strengthening collaboration across the supply chain; expanding education to prepare members for a rapidly changing environment; advancing a unified set of policy priorities through advocacy; and informing members through data-driven insights to support decision-making.
“These priorities have never been more vital,” Moffett said. “Each of us understands how critical medical distribution is to the stability and success of healthcare.”
In her role at Cardinal Health, Moffett leads global quality and regulatory strategy for GMPD, overseeing compliance with U.S. and international regulations and industry standards. She leads an organization of more than 1,500 medical device professionals focused on quality systems, regulatory, medical affairs and scientific services.
Moffett has held leadership roles spanning quality, marketing, product management and strategy. She previously led Global Products within GMPD, where she oversaw Cardinal Health brand and national brand portfolios; OEM partnerships; medical affairs, research and development; and content marketing. She joined Cardinal Health in 2017 following the acquisition of Medtronic’s Patient Recovery business and previously led U.S. strategy and various portfolios for Medtronic’s Patient Recovery and Respiratory businesses.